These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1733640)

  • 21. Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression.
    Sepede G; Racciatti D; Gorgoretti V; Nacci M; Pizzigallo E; Onofrj M; Di Giannantonio M; Niolu C; Salerno RM; Gambi F
    Int J Immunopathol Pharmacol; 2011; 24(4):1017-25. PubMed ID: 22230407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.
    Robertson MJ; Schacterle RS; Mackin GA; Wilson SN; Bloomingdale KL; Ritz J; Komaroff AL
    Clin Exp Immunol; 2005 Aug; 141(2):326-32. PubMed ID: 15996197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic fatigue syndrome following a toxic exposure.
    Racciatti D; Vecchiet J; Ceccomancini A; Ricci F; Pizzigallo E
    Sci Total Environ; 2001 Apr; 270(1-3):27-31. PubMed ID: 11327394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.
    Maes M; Mihaylova I; Kubera M; Ringel K
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):169-75. PubMed ID: 21945535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-mediated immune function and the outcome of chronic fatigue syndrome.
    Wilson A; Hickie I; Lloyd A; Hadzi-Pavlovic D; Wakefield D
    Int J Immunopharmacol; 1995 Aug; 17(8):691-4. PubMed ID: 8847164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunologic and psychosocial status in chronic fatigue syndrome.
    Nas K; Cevik R; Batum S; Sarac AJ; Acar S; Kalkanli S
    Bratisl Lek Listy; 2011; 112(4):208-12. PubMed ID: 21585130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.
    Duffy FH; McAnulty GB; McCreary MC; Cuchural GJ; Komaroff AL
    BMC Neurol; 2011 Jul; 11():82. PubMed ID: 21722376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI
    Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic ACTH autoantibodies are a significant pathological factor in the disruption of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome, anorexia nervosa and major depression.
    Wheatland R
    Med Hypotheses; 2005; 65(2):287-95. PubMed ID: 15885924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals.
    Buchwald D; Pearlman T; Umali J; Schmaling K; Katon W
    Am J Med; 1996 Oct; 101(4):364-70. PubMed ID: 8873506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.
    Anderson G; Berk M; Maes M
    Acta Psychiatr Scand; 2014 Feb; 129(2):83-97. PubMed ID: 23952563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An overview of chronic fatigue syndrome.
    Krupp LB; Mendelson WB; Friedman R
    J Clin Psychiatry; 1991 Oct; 52(10):403-10. PubMed ID: 1938975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological abnormalities in the chronic fatigue syndrome.
    Lloyd AR; Wakefield D; Boughton CR; Dwyer JM
    Med J Aust; 1989 Aug; 151(3):122-4. PubMed ID: 2787888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal analysis of pro- and anti-inflammatory cytokine production in severely fatigued adolescents.
    ter Wolbeek M; van Doornen LJ; Kavelaars A; van de Putte EM; Schedlowski M; Heijnen CJ
    Brain Behav Immun; 2007 Nov; 21(8):1063-74. PubMed ID: 17544255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic fatigue syndrome--a clinically empirical approach to its definition and study.
    Reeves WC; Wagner D; Nisenbaum R; Jones JF; Gurbaxani B; Solomon L; Papanicolaou DA; Unger ER; Vernon SD; Heim C
    BMC Med; 2005 Dec; 3():19. PubMed ID: 16356178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Illness progression in chronic fatigue syndrome: a shifting immune baseline.
    Russell L; Broderick G; Taylor R; Fernandes H; Harvey J; Barnes Z; Smylie A; Collado F; Balbin EG; Katz BZ; Klimas NG; Fletcher MA
    BMC Immunol; 2016 Mar; 17():3. PubMed ID: 26965484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
    Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
    J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic fatigue syndrome, a case of high anti-HHV-6 antibody titer and one associated with primary hyperaldosteronism].
    Kato Y; Kamijima S; Kashiwagi A; Oguri T
    Nihon Rinsho; 1992 Nov; 50(11):2673-8. PubMed ID: 1337563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is depression associated with immune activation?
    Natelson BH; Denny T; Zhou XD; LaManca JJ; Ottenweller JE; Tiersky L; DeLuca J; Gause WC
    J Affect Disord; 1999 May; 53(2):179-84. PubMed ID: 10360413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.